Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PMID: 41203627 Acta Pharmacol Sin Targeting PPAR activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation
:max_bytes(150000):strip_icc()/Simple-7-Day-GLP-1-Friendly-Meal-Plan-for-Beginners-Created-by-a-Dietitian-69f3d02b6c2c41928135df7f0c417552.jpg)
Eric Ravussin, LSU Boyd Professor and director of the Human Translational Physiology Laboratory at Pennington Biomedical, is currently leading the study
Weight loss indications often face insurance coverage challenges
Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective
We verify your coverage and match you with a Waukesha-based provider who accepts your insurance
US$ 28.16
US$ 20.75
US$ 21.09
US$ 29.13
US$ 20.28
US$ 21.23
US$ 22.98
